Hereditary elliptocytosis-associated alpha-spectrin mutation p.L155dup as a modifier of sickle cell disease severity

Pediatr Blood Cancer. 2019 Feb;66(2):e27531. doi: 10.1002/pbc.27531. Epub 2018 Nov 4.

Abstract

The broad phenotypic variability among individuals with sickle cell disease (SCD) suggests the presence of modifying factors. We identified two unrelated SCD patients with unusually severe clinical and laboratory phenotype that were found to carry the hereditary elliptocytosis-associated alpha-spectrin mutation c.460_462dupTTG (p.L155dup), a mutation enriched due to positive selective pressure of malaria, similar to the SCD globin mutations. A high index of suspicion for additional hematologic abnormalities may be indicated for challenging patients with SCD. These cases highlight the validity of specialized testing such as ektacytometry and next-generation sequencing for patients and family members to assess genotype/phenotype correlations.

Keywords: alpha-spectrin; ektacytometry; hereditary elliptocytosis; hereditary pyropoikilocytosis; next-generation sequencing; sickle cell disease.

Publication types

  • Case Reports
  • Research Support, N.I.H., Extramural

MeSH terms

  • Anemia, Sickle Cell / genetics*
  • Child, Preschool
  • Elliptocytosis, Hereditary / genetics
  • Female
  • Genotype
  • Humans
  • Infant
  • Infant, Newborn
  • Male
  • Mutation
  • Pedigree
  • Phenotype
  • Spectrin / genetics*

Substances

  • Spectrin